These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2761678)

  • 1. Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.
    de Witte P; Heidbreder C; Roques BP
    Neuropharmacology; 1989 Jul; 28(7):667-76. PubMed ID: 2761678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1988; 96(3):343-52. PubMed ID: 2851851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of enkephalin metabolism and activation of mu- or delta-opioid receptors elicit opposite effects on reward and motility in the ventral mesencephalon.
    Heidbreder C; Gewiss M; Lallemand S; Roques BP; De Witte P
    Neuropharmacology; 1992 Mar; 31(3):293-8. PubMed ID: 1321359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.
    Calenco-Choukroun G; Daugé V; Gacel G; Féger J; Roques BP
    Psychopharmacology (Berl); 1991; 103(4):493-502. PubMed ID: 1648248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release.
    Petit F; Hamon M; Fournie-Zaluski MC; Roques BP; Glowinski J
    Eur J Pharmacol; 1986 Jul; 126(1-2):1-9. PubMed ID: 3019709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.
    Maldonado R; Daugé V; Feger J; Roques BP
    Neuropharmacology; 1990 Mar; 29(3):215-23. PubMed ID: 2157999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
    Meucci E; Delay-Goyet P; Roques BP; Zajac JM
    Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kelatorphan, a potent enkephalinases inhibitor, presents opposite properties when injected intracerebroventricularly or into the nucleus accumbens on intracranial self-stimulation.
    Heidbreder C; Roques B; Vanderhaeghen JJ; De Witte P
    Neurochem Int; 1988; 12(3):347-50. PubMed ID: 20501237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.
    Vezina P; Kalivas PW; Stewart J
    Brain Res; 1987 Aug; 417(1):51-8. PubMed ID: 3040185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that endogenous enkephalins produce delta-opiate receptor mediated neuronal inhibitions in rat dorsal horn.
    Dickenson AH; Sullivan A; Feeney C; Fournie-Zaluski MC; Roques BP
    Neurosci Lett; 1986 Dec; 72(2):179-82. PubMed ID: 3027626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
    Calenco-Choukroun G; Daugé V; Gacel G; Roques BP
    Eur J Pharmacol; 1991 Dec; 209(3):267-71. PubMed ID: 1665799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors.
    Gosnell BA; Levine AS; Morley JE
    Life Sci; 1986 Mar; 38(12):1081-8. PubMed ID: 2870405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.
    Maldonado R; Feger J; Fournié-Zaluski MC; Roques BP
    Brain Res; 1990 Jun; 520(1-2):247-54. PubMed ID: 2169953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
    Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
    Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerability to stressor-induced disturbances in self-stimulation from the dorsal and ventral A10 area: differential effects of intraventricular D-Ala2-Met5-enkephalinamide, D-Ala2, N-Me-Phe4, Gly-Ol5-enkephalin, and D-Pen2, D-Pen5-enkephalin administration.
    Zacharko RM; Maddeaux C; Hebb AL; Mendella PD; Marsh NJ
    Brain Res Bull; 1998 Oct; 47(3):237-48. PubMed ID: 9865856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.